Mesa Laboratories (NASDAQ:MLAB) Releases Quarterly Earnings Results, Beats Estimates By $0.66 EPS

Mesa Laboratories (NASDAQ:MLAB) posted its quarterly earnings results on Tuesday. The medical instruments supplier reported $2.07 EPS for the quarter, topping analysts’ consensus estimates of $1.41 by $0.66, Zacks reports. Mesa Laboratories had a positive return on equity of 28.52% and a negative net margin of 107.56%.

Mesa Laboratories Trading Up 2.5 %

Shares of NASDAQ MLAB opened at $137.27 on Wednesday. The company has a debt-to-equity ratio of 0.65, a current ratio of 0.70 and a quick ratio of 0.51. The firm’s 50-day moving average price is $133.26 and its two-hundred day moving average price is $125.57. Mesa Laboratories has a 52-week low of $83.68 and a 52-week high of $152.75.

Mesa Laboratories Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Monday, March 17th. Investors of record on Friday, February 28th will be paid a dividend of $0.16 per share. The ex-dividend date is Friday, February 28th. This represents a $0.64 annualized dividend and a yield of 0.47%. Mesa Laboratories’s dividend payout ratio (DPR) is -1.40%.

Analysts Set New Price Targets

Separately, StockNews.com lowered Mesa Laboratories from a “buy” rating to a “hold” rating in a research report on Wednesday, November 13th.

About Mesa Laboratories

Mesa Laboratories, Inc develops, designs, manufactures, sells, and services life sciences tools and quality control products and services in North America, Europe, the Asia Pacific, and internationally. The Sterilization and Disinfection Control segment offers biological, chemical, and cleaning indicators, used to assess the effectiveness of sterilization decontamination, disinfection, and cleaning processes in the pharmaceutical, medical device, and healthcare industries.